Target intelligence / Profile preview

KLRK1 antisense RNA 1 (KLRK1-AS1)

Target
KLRK1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

KLRK1 antisense RNA 1 (KLRK1-AS1) is a long non-coding RNA, transcribed antisense to the KLRK1 gene locus. It is classified as an antisense RNA because it overlaps the mRNA of KLRK1, allowing it to regulate gene expression by mechanisms such as binding and interfering with the stability or processing of its target mRNA, especially at the 3'UTR or regulatory regions. KLRK1-AS1 is known to influence gene expression at both the transcriptional and post-transcriptional levels, including through the recruitment of transcription factors and the modulation of alternative splicing. Bioinformatic and experimental studies indicate KLRK1-AS1 is differentially upregulated in several cancers, indicating a potential role in tumor biology and disease biomarker development[1][3]. Recent evidence also links KLRK1-AS1 expression to wound healing capacity in neonatal endothelial progenitor cells, and its reduction correlates with impaired repair in the context of higher maternal gestational weight gain[5]. There are currently no described direct drug interactions or therapies targeting KLRK1-AS1, and its role is not as a classical receptor, enzyme, or therapeutic target, but rather as a regulatory noncoding RNA within gene networks[2][5].

Other names
LOC101928100TP53LC04RP11-277P12.2012p13.2
02

Biological functions

Regulation of gene expression (negative and positive modulation of mRNA via 3'UTR or splicing region)Modulation of alternative splicing through RNA-binding proteinsPotential involvement in endothelial cell barrier function and wound healing regulation
03

Disease associations

Cancer (differentially expressed in several tumor types, e.g., cervical, esophageal, lung, colon)Possible association with developmental or vascular wound healing defects
04

Biomarkers

Altered expression in cancer tissues versus normalCorrelation of expression with maternal gestational weight gain and wound healing in neonatal cells

Beyond the preview

Go deeper on KLRK1 antisense RNA 1 (KLRK1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLRK1 antisense RNA 1 (KLRK1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call